96 related articles for article (PubMed ID: 25611428)
21. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.
Decker T; Hipp S; Kreitman RJ; Pastan I; Peschel C; Licht T
Blood; 2002 Feb; 99(4):1320-6. PubMed ID: 11830482
[TBL] [Abstract][Full Text] [Related]
22. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
Jahrsdörfer B; Blackwell SE; Wooldridge JE; Huang J; Andreski MW; Jacobus LS; Taylor CM; Weiner GJ
Blood; 2006 Oct; 108(8):2712-9. PubMed ID: 16809616
[TBL] [Abstract][Full Text] [Related]
23. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia.
Eskelund CW; Nederby L; Thysen AH; Skovbo A; Roug AS; Hokland ME
Leuk Res; 2011 Jul; 35(7):914-20. PubMed ID: 21354618
[TBL] [Abstract][Full Text] [Related]
25. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.
Castejón R; Vargas JA; Romero Y; Briz M; Muñoz RM; Durántez A
Cytometry; 1999 Oct; 38(5):224-30. PubMed ID: 10516608
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
27. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Russo M; Spagnuolo C; Volpe S; Tedesco I; Bilotto S; Russo GL
Biochem Pharmacol; 2013 Apr; 85(7):927-36. PubMed ID: 23353698
[TBL] [Abstract][Full Text] [Related]
28. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
29. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
Nerl C; Janssen O; Kabelitz D
Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
[TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
31. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
[TBL] [Abstract][Full Text] [Related]
32. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic and anti-proliferative effects of all-trans retinoic acid. Adenine nucleotide translocase sensitizes HeLa cells to all-trans retinoic acid.
Zamora M; Ortega JA; Alaña L; Viñas O; Mampel T
Exp Cell Res; 2006 Jun; 312(10):1813-9. PubMed ID: 16556444
[TBL] [Abstract][Full Text] [Related]
34. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.
de Vries JF; Falkenburg JH; Willemze R; Barge RM
Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278
[TBL] [Abstract][Full Text] [Related]
35. Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria.
Salimi A; Roudkenar MH; Sadeghi L; Mohseni A; Seydi E; Pirahmadi N; Pourahmad J
Nutr Cancer; 2016; 68(8):1404-1416. PubMed ID: 27779444
[TBL] [Abstract][Full Text] [Related]
36. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression.
Gutierrez A; Arendt BK; Tschumper RC; Kay NE; Zent CS; Jelinek DF
PLoS One; 2011; 6(10):e26056. PubMed ID: 21998751
[TBL] [Abstract][Full Text] [Related]
38. Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells.
Bellosillo B; Colomer D; Pons G; Gil J
Br J Haematol; 1998 Jan; 100(1):142-6. PubMed ID: 9450803
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.
Gupta R; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
J Immunol; 2018 Sep; 201(5):1570-1585. PubMed ID: 30068596
[TBL] [Abstract][Full Text] [Related]
40. Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-CLL).
Aguilar-Santelises M; Amador JF; Mellstedt H; Jondal M
Leuk Res; 1989; 13(10):937-42. PubMed ID: 2586147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
